Who Paid My Doc
Solia
Device Cardiology/Vascular Diseases
PDI 04035479118266
General payments
$2,420,661
Research payments
$4,017,480
Through program year 2025, $2,420,661 in general payments and $4,017,480 in research payments were reported against Solia (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $44,295 | 286 |
| 2025 | Research | $470,903 | 1,866 |
| 2024 | General | $432,462 | 446 |
| 2024 | Research | $648,493 | 3,349 |
| 2023 | General | $193,632 | 261 |
| 2023 | Research | $1,298,176 | 6,184 |
| 2022 | General | $765,137 | 1,123 |
| 2022 | Research | $764,856 | 5,482 |
| 2021 | General | $985,136 | 12,072 |
| 2021 | Research | $835,051 | 6,177 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 35 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
14,188 general · 23,058 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.